Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$12.37 - $13.89 $1.08 Million - $1.22 Million
-87,565 Reduced 44.87%
107,601 $1.4 Million
Q2 2023

Aug 14, 2023

SELL
$11.39 - $13.72 $398,638 - $480,186
-34,999 Reduced 15.21%
195,166 $2.48 Million
Q1 2023

May 15, 2023

BUY
$10.73 - $13.6 $1.92 Million - $2.43 Million
178,600 Added 346.36%
230,165 $2.59 Million
Q4 2022

Feb 14, 2023

BUY
$11.8 - $13.78 $113,964 - $133,087
9,658 Added 23.05%
51,565 $683,000
Q3 2022

Nov 14, 2022

BUY
$11.61 - $15.22 $486,540 - $637,824
41,907 New
41,907 $487,000
Q2 2022

Aug 15, 2022

SELL
$14.32 - $19.88 $2.7 Million - $3.75 Million
-188,758 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$15.39 - $20.25 $1.89 Million - $2.48 Million
122,543 Added 185.07%
188,758 $3.65 Million
Q4 2021

Feb 14, 2022

SELL
$15.91 - $18.72 $224,617 - $264,288
-14,118 Reduced 17.57%
66,215 $1.14 Million
Q3 2021

Nov 15, 2021

BUY
$13.06 - $17.24 $1.05 Million - $1.38 Million
80,333 New
80,333 $1.34 Million
Q1 2021

May 17, 2021

SELL
$11.06 - $12.87 $1.53 Million - $1.78 Million
-138,133 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$9.33 - $12.48 $960,859 - $1.29 Million
-102,986 Reduced 42.71%
138,133 $1.71 Million
Q3 2020

Nov 16, 2020

BUY
$10.33 - $14.49 $1.92 Million - $2.69 Million
185,387 Added 332.64%
241,119 $2.52 Million
Q2 2020

Aug 14, 2020

BUY
$11.49 - $15.26 $640,360 - $850,470
55,732 New
55,732 $779,000
Q1 2020

May 15, 2020

SELL
$8.11 - $15.23 $453,113 - $850,915
-55,871 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$10.28 - $14.38 $205,754 - $287,815
20,015 Added 55.82%
55,871 $791,000
Q3 2019

Nov 14, 2019

BUY
$10.05 - $14.55 $98,831 - $143,084
9,834 Added 37.79%
35,856 $378,000
Q2 2019

Aug 14, 2019

SELL
$13.1 - $14.95 $458,460 - $523,205
-34,997 Reduced 57.35%
26,022 $379,000
Q1 2019

May 15, 2019

BUY
$13.69 - $20.06 $835,350 - $1.22 Million
61,019 New
61,019 $856,000

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.